Cargando…

Venetoclax-Resistant T-ALL Cells Display Distinct Cancer Stem Cell Signatures and Enrichment of Cytokine Signaling

Therapy resistance remains one of the major challenges for cancer treatment that largely limits treatment benefits and patient survival. The underlying mechanisms that lead to therapy resistance are highly complicated because of the specificity to the cancer subtype and therapy. The expression of th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shah, Kinjal, Al Ashiri, Lina, Nasimian, Ahmad, Ahmed, Mehreen, Kazi, Julhash U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003524/ https://www.ncbi.nlm.nih.gov/pubmed/36902436 http://dx.doi.org/10.3390/ijms24055004

Ejemplares similares

A Receptor Tyrosine Kinase Inhibitor Sensitivity Prediction Model Identifies AXL Dependency in Leukemia
por: Nasimian, Ahmad, et al.
Publicado: (2023)

T-cell Acute Lymphoblastic Leukemia Cells Display Activation of Different Survival Pathways
por: Moharram, Sausan A., et al.
Publicado: (2017)

A deep tabular data learning model predicting cisplatin sensitivity identifies BCL2L1 dependency in cancer
por: Nasimian, Ahmad, et al.
Publicado: (2023)

The Aurora kinase/β-catenin axis contributes to dexamethasone resistance in leukemia
por: Shah, Kinjal, et al.
Publicado: (2021)

Acute leukemia cells resistant to PI3K/mTOR inhibition display upregulation of P2RY14 expression
por: Shah, Kinjal, et al.
Publicado: (2018)

PLK1 as a cooperating partner for BCL2-mediated antiapoptotic program in leukemia
por: Shah, Kinjal, et al.
Publicado: (2023)

Glucocorticoid-resistant B cell acute lymphoblastic leukemia displays receptor tyrosine kinase activation
por: Chougule, Rohit A., et al.
Publicado: (2019)

Phosphorylation-Dependent Regulation of WNT/Beta-Catenin Signaling
por: Shah, Kinjal, et al.
Publicado: (2022)

Understanding the Role of Activation Loop Mutants in Drug Efficacy for FLT3-ITD
por: Kazi, Julhash U., et al.
Publicado: (2023)

T cell receptor (TCR) signaling in health and disease
por: Shah, Kinjal, et al.
Publicado: (2021)

The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
por: Moharram, Sausan A., et al.
Publicado: (2019)

Correction: The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
por: Moharram, Sausan A., et al.
Publicado: (2019)

Mechanisms of Anticancer Therapy Resistance: The Role of Cancer Stem Cells
por: Kazi, Julhash U.
Publicado: (2020)

Venetoclax imparts distinct cell death sensitivity and adaptivity patterns in T cells
por: Ludwig, Lindsey M., et al.
Publicado: (2021)

ABL2 suppresses FLT3-ITD-induced cell proliferation through negative regulation of AKT signaling
por: Kazi, Julhash U., et al.
Publicado: (2017)

Biophysical subsets of embryonic stem cells display distinct phenotypic and morphological signatures
por: Bongiorno, Tom, et al.
Publicado: (2018)

Reprogrammed Cells Display Distinct Proteomic Signatures Associated with Colony Morphology Variability
por: Bjørlykke, Yngvild, et al.
Publicado: (2019)

Src-Like Adaptor Protein (SLAP) Binds to the Receptor Tyrosine Kinase Flt3 and Modulates Receptor Stability and Downstream Signaling
por: Kazi, Julhash U., et al.
Publicado: (2012)

Multiple Sclerosis CSF Is Enriched With Follicular T Cells Displaying a Th1/Eomes Signature
por: Morille, Jérémy, et al.
Publicado: (2022)

Skin-infiltrating T cells display distinct inflammatory signatures in lichen planus, bullous pemphigoid and pemphigus vulgaris
por: Schinner, Jona, et al.
Publicado: (2023)

Comparative analysis of human and bovine protein kinases reveals unique relationship and functional diversity
por: Kabir, Nuzhat N., et al.
Publicado: (2011)

Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication
por: Lu, Pin, et al.
Publicado: (2021)

The Src family kinase LCK cooperates with oncogenic FLT3/ITD in cellular transformation
por: Marhäll, Alissa, et al.
Publicado: (2017)

FYN expression potentiates FLT3-ITD induced STAT5 signaling in acute myeloid leukemia
por: Chougule, Rohit A., et al.
Publicado: (2016)

Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis
por: Ke, Hengning, et al.
Publicado: (2016)

Machine learning in the prediction of cancer therapy
por: Rafique, Raihan, et al.
Publicado: (2021)

Hepatocellular Carcinoma Displays Distinct DNA Methylation Signatures with Potential as Clinical Predictors
por: Hernandez-Vargas, Hector, et al.
Publicado: (2010)

Human Primary Bone Marrow Mesenchymal Stromal Cells and Their in vitro Progenies Display Distinct Transcriptional Profile Signatures
por: Ghazanfari, Roshanak, et al.
Publicado: (2017)

Venetoclax treatment of patients with relapsed T-cell prolymphocytic leukemia
por: Hampel, Paul J., et al.
Publicado: (2021)

Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures
por: Sabry, May, et al.
Publicado: (2019)

Proinflammatory Innate Cytokines and Distinct Metabolomic Signatures Shape the T Cell Response in Active COVID-19
por: Binayke, Akshay, et al.
Publicado: (2022)

Prediction of venetoclax activity in precursor B-ALL by functional assessment of apoptosis signaling
por: Seyfried, Felix, et al.
Publicado: (2019)

SRC-like adaptor protein 2 (SLAP2) is a negative regulator of KIT-D816V-mediated oncogenic transformation
por: Rupar, Kaja, et al.
Publicado: (2018)

Relapsed/Refractory ETP-ALL Successfully Treated With Venetoclax and Nelarabine as a Bridge to Allogeneic Stem Cell Transplant
por: McEwan, Ashley, et al.
Publicado: (2020)

ASXL1 mutations are associated with distinct epigenomic alterations that lead to sensitivity to venetoclax and azacytidine
por: Rahmani, Nora E., et al.
Publicado: (2021)

DLBCL Cells with Acquired Resistance to Venetoclax Are Not Sensitized to BIRD-2 But Can Be Resensitized to Venetoclax through Bcl-XL Inhibition
por: Kerkhofs, Martijn, et al.
Publicado: (2020)

Human decidual macrophages and NK cells differentially express Toll-like receptors and display distinct cytokine profiles upon TLR stimulation
por: Duriez, Marion, et al.
Publicado: (2014)

Five inhibitory receptors display distinct vesicular distributions in T cells
por: Lu, Jiahe, et al.
Publicado: (2023)

Single-cell deep phenotyping of cytokine release unmasks stimulation-specific biological signatures and distinct secretion dynamics
por: Portmann, Kevin, et al.
Publicado: (2023)

Two Distinct Clinical Patterns of Ibrutinib-to-Venetoclax Transition in Relapsed Chronic Lymphocytic Leukemia Patients
por: Ferrarini, Isacco, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j83aktjpa64pmn85p6bqcijjbt